Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella
Robert M. F. van der Put, Carolien Smitsman, Alex de Haan, et al.
ACS Central Science (2022) Vol. 8, Iss. 4, pp. 449-460
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
Linda Del Bino, Kitt Emilie Østerlid, Dung‐Yeh Wu, et al.
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15672-15716
Open Access | Times Cited: 108
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines
Rajendra Rohokale, Zhongwu Guo
ACS Infectious Diseases (2023) Vol. 9, Iss. 2, pp. 178-212
Open Access | Times Cited: 44
Advances in glycoside and oligosaccharide synthesis
C. Crawford, Peter H. Seeberger
Chemical Society Reviews (2023) Vol. 52, Iss. 22, pp. 7773-7801
Open Access | Times Cited: 41
Recent chemical synthesis and immunological evaluation of glycans related to bacterial lipopolysaccharides
Chunjun Qin, Guangzong Tian, Jing Hu, et al.
Current Opinion in Chemical Biology (2024) Vol. 78, pp. 102424-102424
Closed Access | Times Cited: 10
Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans
C. Crawford, Livia Liporagi-Lopes, Carolina Coelho, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 2089-2100
Open Access | Times Cited: 8
Carriers and Antigens: New Developments in Glycoconjugate Vaccines
Robert M. F. van der Put, Bernard Metz, Roland J. Pieters
Vaccines (2023) Vol. 11, Iss. 2, pp. 219-219
Open Access | Times Cited: 20
Shigella Vaccines: The Continuing Unmet Challenge
Ti Lu, Sayan Das, Debaki Ranjan Howlader, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4329-4329
Open Access | Times Cited: 7
Development of a Novel mRNA Vaccine Against Shigella Pathotypes Causing Widespread Shigellosis Endemic: An In-Silico Immunoinformatic Approach
Abdur Razzak, Otun Saha, Khandokar Fahmida Sultana, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges
Armelle Phalipon, Laurence A. Mulard
Vaccines (2022) Vol. 10, Iss. 3, pp. 403-403
Open Access | Times Cited: 21
Chemical Synthesis and Antigenicity Evaluation of Shigella dysenteriae Serotype 10 O-Antigen Tetrasaccharide Containing a (S)-4,6-O-Pyruvyl Ketal
Chunjun Qin, Lingxin Li, Guangzong Tian, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 46, pp. 21068-21079
Closed Access | Times Cited: 19
Total Synthesis of a Rare-Sugar-Enriched O-Antigenic Tetrasaccharide Repeating Unit of Acinetobacter lwoffii EK30A
Subhas Chandra Jana, Mrinmoy Manash Bharali, Abhishek Santra
The Journal of Organic Chemistry (2025)
Closed Access
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
Shiri Meron-Sudai, Valeria Asato, Amos Adler, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
Meagan Kelly, Anjali Mandlik, Richelle C. Charles, et al.
Vaccine (2023) Vol. 41, Iss. 34, pp. 4967-4977
Open Access | Times Cited: 7
Impact of Protein Nanoparticle Shape on the Immunogenicity of Antimicrobial Glycoconjugate Vaccines
Marta Dolce, Daniela Proietti, Silvia Principato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3736-3736
Open Access | Times Cited: 2
Protecting group principles suited to late stage functionalization and global deprotection in oligosaccharide synthesis
Debashis Dhara, Ashis Dhara, Paul V. Murphy, et al.
Carbohydrate Research (2022) Vol. 521, pp. 108644-108644
Open Access | Times Cited: 11
Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice
Arun Naini, Max P. Bartetzko, Someswara Rao Sanapala, et al.
JACS Au (2022) Vol. 2, Iss. 9, pp. 2135-2151
Open Access | Times Cited: 11
Scalable production of microscopic particles for biological delivery
Huoyue Lin, Jing Leng, Pingqing Fan, et al.
Materials Advances (2023) Vol. 4, Iss. 14, pp. 2885-2908
Open Access | Times Cited: 6
Impact and Control of Sugar Size in Glycoconjugate Vaccines
Giuseppe Stefanetti, Calman A. MacLennan, Francesca Micoli
Molecules (2022) Vol. 27, Iss. 19, pp. 6432-6432
Open Access | Times Cited: 10
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (Invaplex AR ) vaccines
K. Ross Turbyfill, Kristen A. Clarkson, Edwin V. Oaks, et al.
mSphere (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 5
Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target
Alan S. Cross
Microbiology and Molecular Biology Reviews (2023) Vol. 87, Iss. 3
Open Access | Times Cited: 5
Synthetic BSA-conjugated disaccharide related to the Streptococcus pneumoniae serotype 3 capsular polysaccharide increases IL-17A Levels, γδ T cells, and B1 cells in mice
Н. К. Ахматова, Е. А. Курбатова, Anton E. Zaytsev, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge
Meagan Kelly, Jeshina Janardhanan, Chanchal Wagh, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126263-126263
Open Access | Times Cited: 1
Semi-synthetic glycoconjugate vaccine candidate againstCryptococcus neoformans
C. Crawford, Livia C. Liporagi-Lopes, Carolina Coelho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Synthesis and immunogenicity evaluation of oligosaccharide epitopes for the development of a glycoconjugate vaccine against Streptococcus pneumoniae serotype 3
Xiaolin Ma, Jielin Zhao, Guirong Wang, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 9, pp. 2539-2547
Closed Access
Development of a Novel Mrna Vaccine Against Shigella Pathotypes Causing Widespread Shigellosis Endemic: An In-Silico Immunoinformatic Approach
Abdur Razzak, Otun Saha, Nikkon Sarker, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top